Skip to main content
TipRanks
Go Ultimate75% OFF

Urogen Pharma (UR8) Ownership - Who Owns Urogen Pharma?

1 Followers

Urogen Pharma (UR8) Ownership Overview

  • 1.77% Insiders
  • 5.60% Mutual Funds
  • 17.98% Other Institutional Investors
  • 7.50% ETFs
  • 67.14% Public Companies and Individual Investors

The ownership structure of Urogen Pharma (DE:UR8) stock is a mix of institutional, retail, and individual investors. Approximately 31.09% of the company’s stock is owned by Institutional Investors, 1.77% is owned by Insiders, and 67.14% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 23, 2026Mark Schoenberg$2,854,853
Feb 03, 2026Mark Schoenberg$145,174

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Aisling Capital Management Lp€2,529,360
Dec 31, 2025Ark Investment Management Llc€2,845,155
Dec 31, 2025Woodline Partners Lp€11,727,002

Top Shareholders

DE:UR8 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.3,108,202Institution6.34%79,308,882
Ishares2,260,672Institution4.61%57,683,307
American Century Mutual Funds, Inc.874,981Institution1.78%22,326,015
Fidelity Salem Street Trust507,789Institution1.04%12,956,744
Michael Rockefeller500,726Institution1.02%12,776,525
Vanguard470,752Institution0.96%12,011,708
Vanguard Scottsdale Funds420,842Institution0.86%10,738,204
Arie Belldegrun408,693Insider0.83%10,428,211
Elizabeth A. Barrett326,691Insider0.67%8,335,848
Fidelity255,238Institution0.52%6,512,653

Top Mutual Fund Holders

DE:UR8 top mutual fund holders
Holder# of SharesType% HoldingValue
American Century Mutual Funds, Inc.874,981Institution1.78%22,326,015
Fidelity Salem Street Trust507,789Institution1.04%12,956,744
Vanguard Scottsdale Funds420,842Institution0.86%10,738,204
Tiaa-cref Funds158,899Institution0.32%4,054,467
Schwab Capital Trust126,848Institution0.26%3,236,654
Vanguard World Fund118,428Institution0.24%3,021,809
Valic Co I113,987Institution0.23%2,908,492
Clearwater Investment Trust67,706Institution0.14%1,727,586
Federated Hermes Mdt Series60,521Institution0.12%1,544,254
Russell Investment Co46,964Institution0.10%1,198,333

FAQ

Who Owns Urogen Pharma (DE:UR8)?
According to the latest TipRanks data, approximately 31.09% of the company's stock is held by institutional investors, 1.77% is held by insiders, and 67.14% is held by public companies and individual investors.
What percentage of Urogen Pharma (DE:UR8) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.09% of Urogen Pharma (DE:UR8) stock is held by institutional investors: 5.60% by mutual funds, 7.50% by ETFs and 17.98% by other institutional investors.
What percentage of Urogen Pharma (DE:UR8) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.14% of Urogen Pharma (DE:UR8) stock is held by public companies and individual investors.
Who owns the most shares of Urogen Pharma (DE:UR8)?
BlackRock, Inc. owns the most shares of Urogen Pharma (DE:UR8).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.